FindTrial
Sign In

Evaluation of 30 day Morbidity and Mortality of Laparoscopic Cholecystectomy In India

Evaluation of 30 day Morbidity and Mortality of Laparoscopic Cholecystectomy In India- A prospective multicenter cohort study - Lap chole In India

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/11/029448
Enrollment
5000
Registered
2020-11-28
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K812- Acute cholecystitis with chronic cholecystitis

Interventions

None listed

Sponsors

Dr Ramen Goel
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All Adult patients who get operated by registered surgeons for laparoscopic cholecystectomy ( Emergency/ Elective ) from 1st December 2020 to 28th February 2021 will be included in the study.

Exclusion criteria

Exclusion criteria: Patients undergoing cholecystectomy for malignancy; Operations performed outside the above dates; Children and young adults ( <18 years of age); Operations performed outside India.

Design outcomes

Primary

MeasureTime frame
Morbidity and Mortality at 30 days post laparoscopic cholecystectomyTimepoint: Morbidity and Mortality at 30 days post laparoscopic cholecystectomy—

Secondary

MeasureTime frame
Factors responsible for morbidity and mortality will be assessed Patient factors( age/ comorbidities/ sex/ BMI) Disease factors ( acute cholecystitis/ impacted calculus/ shrunken gall bladder/ Gngrenous/ Perforated / empyema) Surgeon factors ( Private nursing home/ private Institute/ teaching institute , surgeons experience Timepoint: 4 WEEKS After surgery—

Countries

India

Contacts

Public ContactDr Pinky Thapar

Jupiter Hospital, Thane

pinkythapar71@gmail.com9322222188

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026